By Greg Ryan ( May 11, 2012, 4:20 PM EDT) -- A Canadian court has refused to certify a class of users of antipsychotic treatment Seroquel who claim AstraZeneca Pharmaceuticals PLC misled consumers about the safety of the drug, striking a significant north-of-the-border blow on May 7 to litigation that is all but resolved in the U.S....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.